Early and advanced glycosylation end products. Kinetics of formation and clearance in peritoneal dialysis

The Journal of Clinical Investigation
M FriedlanderV M Monnier

Abstract

The chronic contact of glucose-containing dialysate and proteins results in the deposition of advanced glycation end products (AGEs) on peritoneal tissues in patients treated by peritoneal dialysis (PD), yet plasma levels of the AGE pentosidine are significantly lower in PD than in hemodialysis (HD). We measured glycation of peritoneal proteins in patients on PD over the time course of intraperitoneal equilibration of fresh peritoneal dialysate. The glycated content of peritoneal proteins (furosine method) was initially identical to plasma but increased 200% within 4 h due to in situ glycation as also demonstrated in vitro. In contrast, peritoneal proteins contained a 2-4 x greater content of the AGE pentosidine at all equilibrium time points. Plasma protein furosine content was identical in patients on PD and on HD. Fractionation by gel filtration of serum from patients on PD and HD revealed that > 95% of the pentosidine was linked to proteins > 10,000 mol wt; < 1% to proteins < 10,000 mol wt; and < 1%, free. Neither HD nor PD affected protein-bound pentosidine. The HD treatment decreased free and < 10,000 mol wt bound pentosidine. However clearance of protein-associated pentosidine by the peritoneal membrane may explain lower...Continue Reading

References

Sep 19, 1991·The New England Journal of Medicine·Z MakitaH Vlassara
Sep 1, 1984·Kidney International·J T Dulaney, F E Hatch
Jan 1, 1984·Kidney International·G A Kaysen, P Y Schoenfeld
Apr 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·S K WilliamsM W Bitensky
May 19, 1995·Journal of Chromatography. B, Biomedical Applications·Y C WuM Friedlander
Mar 1, 1995·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·M A FriedlanderD E Hricik
Oct 1, 1993·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·S M KorbetH Vlassara
Dec 1, 1993·The Journal of Clinical Investigation·S S AndersonA S Charonis
Jul 1, 1993·The Journal of Clinical Investigation·P J BeisswengerT J Curphey
Feb 1, 1993·Kidney International·D E HricikV M Monnier
Jun 1, 1993·The Journal of Clinical Investigation·D R McCanceT J Lyons

❮ Previous
Next ❯

Citations

Aug 26, 2000·Clinica Chimica Acta; International Journal of Clinical Chemistry·S FrankeG Stein
Dec 23, 1998·Mechanisms of Ageing and Development·D R SellV M Monnier
Jun 9, 2000·Kidney International·M F WeissV M Monnier
Dec 15, 2000·Kidney International·Y UedaC Van Ypersele De Strihou
Feb 19, 2002·Kidney International·Toshio MiyataCharles van Ypersele de Strihou
Nov 10, 2011·The Journal of Biological Chemistry·Christian HenningMarcus A Glomb
May 14, 2009·Molecular & Cellular Proteomics : MCP·Jiaqian NiUNKNOWN Clinical Genomic and Proteomic AMD Study Group
Jun 6, 2009·Antioxidants & Redox Signaling·Anne Negre-SalvayreManuel Portero-Otín
May 5, 2000·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·M TakahashiA Nagano
Dec 13, 2003·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Alessandro AmoreRosanna Coppo
Mar 12, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Sophie IgnaceFitsum Guebre-Egziabher
May 3, 2012·Seminars in Dialysis·Sandeep K MallipattuJaime Uribarri
May 19, 2005·Clinical Chemistry and Laboratory Medicine : CCLM·Xiaohong ZhangMonika Pischetsrieder
Jun 3, 2011·Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis·Caatje Y le PooleCasper G Schalkwijk
Nov 14, 1997·European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies·G MünchR Schinzel
Feb 13, 2001·Kidney International. Supplement·N LameireR De Smet
Feb 13, 2001·Kidney International. Supplement·W R Clark, L W Henderson
Jan 18, 2011·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Takatoshi KakutaAkira Saito
Mar 30, 2010·Revista española de geriatría y gerontología·Alba NaudíReinald Pamplona
Nov 28, 2008·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Robbert MeerwaldtAndries J Smit
Jul 31, 2007·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Liang LuMiriam F Weiss
Jul 23, 2005·Annals of the New York Academy of Sciences·A LapollaP Traldi
Jul 23, 2005·Annals of the New York Academy of Sciences·Vincent M MonnierSaul Genuth
Jul 23, 2005·Annals of the New York Academy of Sciences·S AgalouA Dawnay
Jul 6, 2005·British Journal of Pharmacology·Julián NevadoLeocadio Rodríguez-Mañas
Oct 1, 2004·Hemodialysis International·William D SchwingMiriam F Weiss
Jan 12, 2005·Clinical Biochemistry·Annunziata LapollaDomenico Fedele
Jul 11, 2006·Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation·Paul J Thornalley
May 29, 2012·International Journal of Biological Macromolecules·Reza YousefiAli-Akbar Moosavi-Movahedi
Jun 2, 2000·Seminars in Dialysis·J Heaf
Nov 10, 2000·Advances in Renal Replacement Therapy·G A Coles, N Topley
Jun 20, 2007·Hemodialysis International·Amy Ruth Godfrey
Apr 1, 2005·Journal of the American Society of Nephrology : JASN·Stamatina AgalouPaul J Thornalley
Jan 20, 2006·Journal of Mass Spectrometry : JMS·Annunziata LapollaPietro Traldi
May 1, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·G SteinJ Vienken
Dec 6, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·A S De VrieseN H Lameire
Apr 6, 2000·American Journal of Physiology. Renal Physiology·V ScivittaroM F Weiss
Aug 11, 2020·Journal of Biomolecular Structure & Dynamics·Afreen KhanamSaheem Ahmad

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.